Featured News
723Wire StoriesLatest Data of InnoCare’s Orelabrutinib for the Treatment of SLE Presented at LBA Session of EULAR 2022
BEIJING–(BUSINESS WIRE)–InnoCare Pharma (HKEX: 09969), a leading biotech company, announced today that Professor Zhanguo Li, the leading PI, has presented latest data...
- 568Wire Stories
Energy Transfer Signs LNG Sale and Purchase Agreement With China Gas
25-Year Agreement for LNG for Supply from Energy Transfer’s Lake Charles LNG Export Facility Represents First Long-Term LNG Contract Signed by China...
- 679Wire Stories
ENHERTU® Reduced the Risk of Disease Progression or Death by 50% vs. Chemotherapy in Patients with HER2 Low Metastatic Breast Cancer with HR Positive and HR Negative Disease
Daiichi Sankyo and AstraZeneca’s ENHERTU also improved median overall survival by more than 6 months vs. chemotherapy in all patients evaluated in...
- 526News
Sino Jet Announces Carbon Neutrality Plan
HONG KONG SAR – Media OutReach – 5 June 2022 – On World Environment Day, 5th June 2022, Chinese business jet company...
- 621Wire Stories
MEI Pharma and Kyowa Kirin Report New Clinical Data on Zandelisib at American Society of Clinical Oncology Annual Meeting 2022
– Zandelisib Demonstrated 70.3% Objective Response Rate and 35.2% Complete Response Rate – – 87.5% of Responses Achieved in First Two Cycles...
- 561Wire Stories
Cubic Technology Launched to Provide Easier Rail Journeys for Queensland Commuters
Cubic Transportation Systems launches the first credit card and smart device-compatible gates on Queensland’s Heavy Rail Network, giving more payment options to...
- 559Wire Stories
Kite Realty Group Trust to Present at NAREIT’s REITweek: 2022 Investor Conference
INDIANAPOLIS, June 03, 2022 (GLOBE NEWSWIRE) — Kite Realty Group Trust (NYSE: KRG) announced today that it will present at Nareit’s REITweek:...
- 493Wire Stories
Global Commercial Vehicle Surround View System Markets, 2021-2030: Revenue, Trends, Growth Opportunities, Competition, End Cases – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Commercial Vehicle Surround View System Market – Revenue, Trends, Growth Opportunities, Competition, COVID-19 Strategies, Regional Analysis and Future Outlook to...
- 527Wire Stories
Zai Lab and Novocure Announce EF-31 Phase 2 Pilot Study Evaluating Tumor Treating Fields Together with Standard-of-Care Chemotherapy Meets Primary Endpoint for First-Line Treatment of Gastric Cancer
Confirmed objective response rate was 50% for patients treated with TTFields together with standard-of-care chemotherapy Duration of response was 10.3 months One-year...
- 528Wire Stories
Patritumab Deruxtecan Continues to Show Promising Clinical Activity in Patients Across Subtypes of Metastatic Breast or Lung Cancer
Data from a phase 1/2 trial in patients with several subtypes of HER3 expressing metastatic breast cancer featured as oral presentation at...
- 519Wire Stories
Patritumab Deruxtecan Continues to Show Promising Clinical Activity in Patients Across Subtypes of Metastatic Breast or Lung Cancer
Data from a phase 1/2 trial in patients with several subtypes of HER3 expressing metastatic breast cancer featured as oral presentation at...
